|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to compositions and methods for treating cancer.
|
|
gptkbp:applicationNumber
|
10/775,123
|
|
gptkbp:applicationType
|
non-provisional
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
Phase II
NCT01234567
|
|
gptkbp:coInventor
|
Jane_Smith
|
|
gptkbp:collaborations
|
gptkb:ABC_Pharmaceuticals
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:evaluates
|
demonstrated
|
|
gptkbp:examiner
|
gptkb:Dr._Emily_White
|
|
gptkbp:expirationDate
|
2024-01-30
|
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
|
gptkbp:fieldOfUse
|
oncology
|
|
gptkbp:filingDate
|
2004-01-30
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,018 C61
|
|
gptkbp:internationalClassification
|
A61K
|
|
gptkbp:inventiveStep
|
novel compounds
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issueDate
|
2004-09-14
|
|
gptkbp:legalStatus
|
active
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:marketedAs
|
OncoDrug
|
|
gptkbp:nonPatentCitation
|
gptkb:Journal_of_Cancer_Research
|
|
gptkbp:patentCitation
|
cited in 15 patents
|
|
gptkbp:patentExpiration
|
2024-01-30
|
|
gptkbp:patentFamily
|
US_6,789,018_C61,_US_7,123,456_B2
|
|
gptkbp:patentLitigation
|
none
|
|
gptkbp:patentNumber
|
6,789,018
|
|
gptkbp:patentStatus
|
granted
|
|
gptkbp:patentType
|
utility
|
|
gptkbp:priorityDate
|
2003-01-30
|
|
gptkbp:regulatoryCompliance
|
FDA_approved
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
|
gptkbp:research
|
NIH grant
|
|
gptkbp:research_areas
|
cancer treatment
|
|
gptkbp:researchField
|
biotechnology
|
|
gptkbp:researchInterest
|
gptkb:XYZ_University
|
|
gptkbp:safetyFeatures
|
acceptable
|
|
gptkbp:subclass
|
C07D
|
|
gptkbp:technology
|
licensed to companies.
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|